Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Norwegian University of Science and Technology St. Olavs Hospital |
---|---|
Information provided by: | Norwegian University of Science and Technology |
ClinicalTrials.gov Identifier: | NCT00246545 |
The aim of the study is to evaluate the effect of early onset of exercise training (ET) after myocardial infarction (MI) in a randomized controlled trial.Usual care is to wait 4-6 weeks after onset of MI, and our hypotheses are that early ET will prevent a fall in VO2peak and contribute to better quality of life.
Condition | Intervention | Phase |
---|---|---|
Myocardial Infarction |
Behavioral: exercise |
Phase II |
Study Type: | Interventional |
Study Design: | Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Effect Evaluation of Early Exercise Training After Myocardial Infarction |
Estimated Enrollment: | 60 |
Study Start Date: | October 2005 |
Study Completion Date: | December 2007 |
Primary Completion Date: | December 2007 (Final data collection date for primary outcome measure) |
Exercise training is well documented as effective treatment for MI patents. However, the long time effect of early onset is more unclear, and it is needed to provide knowledge about to which extend early onset of ET contribute to reduce risk factors, increase oxygen consumption and influence on quality of life.
A RCT is conducted, 60 persons with recently MI is invited to participate. The subjects participating is hospitalised in St. Olavs Hospital. The participants is randomised to either a training group or a control group.
The training group will be offered hospital out-patient group exercise training of moderate intensity twice a week for four weeks. The training is leaded by a physiotherapist. The control group will wait four weeks before both groups continue ET twice a week for 12 weeks(high intensity training).
Ages Eligible for Study: | 18 Years to 90 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Norway, Sør-Trøndelag | |
St. Olavs Hospital | |
Trondheim, Sør-Trøndelag, Norway, 7006 |
Study Director: | Asbjørn Støylen, Dr.med | NTNU, St.Olavs hospital |
Principal Investigator: | Ingerlise Aamot, PT | St. Olavs Hospital |
Responsible Party: | Norwegian University of Science and Technology ( Asbjorn Stoylen ) |
Study ID Numbers: | fase I |
Study First Received: | October 28, 2005 |
Last Updated: | February 4, 2009 |
ClinicalTrials.gov Identifier: | NCT00246545 History of Changes |
Health Authority: | Norway: Norwegian Social Science Data Services |
Necrosis Heart Diseases Myocardial Ischemia Vascular Diseases |
Ischemia Infarction Myocardial Infarction |
Necrosis Heart Diseases Pathologic Processes Myocardial Ischemia Vascular Diseases |
Cardiovascular Diseases Ischemia Infarction Myocardial Infarction |